Search

Repligen Corp

Open

SectorHealthcare

174.02 4.83

Overview

Share price change

24h

Current

Min

165.33

Max

174.44

Key metrics

By Trading Economics

Income

-3.3M

5M

Sales

9.9M

204M

P/E

Sector Avg

226.487

56.597

EPS

0.54

Profit margin

2.453

Employees

2,000

EBITDA

-35M

-2.4M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+9.64% upside

Dividends

By Acuity

Next Earnings

27 paź 2026

Market Stats

By TradingEconomics

Market Cap

2.1B

9.5B

Previous open

169.19

Previous close

174.02

News Sentiment

By Acuity

34%

66%

60 / 339 Ranking in Healthcare

Repligen Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

14 wrz 2026, 19:46 UTC

Repligen Corp shares are higher today, continuing an upward trend since Friday. The stock has fluctuated within a range during the session.

11 wrz 2026, 21:01 UTC

Repligen Corp shares are higher in after-market trading, continuing an upward trend since Friday's close. The stock remains below its 20-day moving average.

10 wrz 2026, 20:07 UTC

Repligen Corp shares are lower amid broader market declines following the European Central Bank's interest rate hike and rising Treasury yields.

9 wrz 2026, 20:07 UTC

Repligen Corp shares are lower during Wednesday's session, with no specific news identified. The stock remains significantly below its 20-day moving average.

8 wrz 2026, 22:21 UTC

Repligen Corp shares declined in after-market trading, falling further from Tuesday's close and remaining near the lower end of their one-month trading range.

2 wrz 2026, 19:26 UTC

Repligen Corp shares are higher during Wednesday's session, reaching a session high earlier today. The stock shows resilience amid broader market geopolitical tensions.

1 wrz 2026, 20:01 UTC

Repligen Corp shares are lower today, continuing a decline from Monday's close amid rising oil prices and inflation concerns affecting market conditions.

31 sie 2026, 21:02 UTC

Repligen Corp shares are lower in after-market hours amid broader economic concerns and hawkish comments from Fed Chair Kevin Warsh on inflation and interest rates.

28 sie 2026, 23:01 UTC

Repligen Corp shares are higher in after-market hours, reflecting strong momentum and positioning near the upper end of their one-month trading range.

26 sie 2026, 19:46 UTC

News

Repligen Corp shares are lower during Wednesday's session amid broader market volatility and persistent inflationary pressures reflected in recent PCE data.

25 sie 2026, 22:01 UTC

Repligen Corp shares are lower in after-market trading, reflecting broader market caution ahead of key economic events and a drop in consumer confidence.

24 sie 2026, 19:36 UTC

Repligen Corp shares are higher today, continuing an upward trend since Friday. The stock showed volatility, peaking earlier in the session.

21 sie 2026, 22:31 UTC

Correlated Moves

Repligen Corp's after-market performance is roughly flat, reflecting a slight decline since Friday's close amid broader market weakness in the life sciences sector.

20 sie 2026, 19:51 UTC

Repligen Corp is gaining during Thursday's session, supported by strong movement in the Life Sciences Tools & Services sub-sector. Shares pulled back earlier but have advanced.

19 sie 2026, 20:02 UTC

Repligen Corp is advancing sharply, supported by gains in the Life Sciences Tools & Services sub-sector. The stock remains above its 20-day moving average.

18 sie 2026, 19:36 UTC

Repligen Corp shares are declining, continuing a downward trend since Monday. Broader market sentiment remains cautious amid rising treasury yields and inflation concerns.

14 sie 2026, 19:16 UTC

Repligen Corp shares are lower today amid a lack of specific news. Investor sentiment is cautious following a decline in U.S. retail sales.

13 sie 2026, 22:01 UTC

Repligen Corp shares are lower in after-market hours, dropping from a brief high. The price remains above its 20-day moving average.

12 sie 2026, 19:36 UTC

Repligen Corp shares are higher today amid broader market optimism following a modest increase in the core Consumer Price Index. No specific company news was identified.

11 sie 2026, 20:01 UTC

Repligen Corp shares are higher today, reflecting strong performance amid routine trading. The stock remains above its 20-day moving average.

10 sie 2026, 23:16 UTC

Repligen Corp shares are trading higher in after-market hours. The stock remains near the upper end of its one-month trading range.

7 sie 2026, 22:01 UTC

Repligen Corp shares are higher in after-market trading, continuing a trend of six consecutive sessions. Broader equity gains follow weaker employment data easing rate hike concerns.

6 sie 2026, 20:02 UTC

Repligen Corp shares are higher today, continuing gains from Wednesday. No specific company news was identified to explain the movement.

5 sie 2026, 20:02 UTC

Correlated Moves

Repligen Corp shares are higher today, bolstered by gains in Charles River Laboratories and positive sentiment in the life sciences sector.

4 sie 2026, 19:56 UTC

Repligen Corp shares are higher today, reflecting broader market strength amid a significant decline in crude oil prices. The stock is near its one-month range's upper end.

31 lip 2026, 20:02 UTC

Repligen Corp shares are lower today amid broader market pressures and rising US Treasury yields. The stock reached a session low earlier.

30 lip 2026, 21:02 UTC

Repligen Corp shares are higher in after-market trading, buoyed by positive investor sentiment amid a focus on corporate earnings and broader market trends.

29 lip 2026, 16:12 UTC

Repligen Corp shares are lower Wednesday, breaking a trend of higher daily closes. Broader market conditions reflect rising crude oil prices and inflation concerns.

28 lip 2026, 23:21 UTC

Repligen Corp shares are higher in after-market trading, reflecting strong momentum and trading near the upper end of its one-month range.

27 lip 2026, 16:26 UTC

News

Repligen Corporation shares are lower as the company approaches its Q2 earnings report, with analysts projecting 10.7% revenue growth. Current price is $131.96.

Peer Comparison

Price change

Repligen Corp Forecast

Price Target

By TipRanks

9.64% upside

12 Months Forecast

Average 184.2 USD  9.64%

High 225 USD

Low 145 USD

Based on 12 Wall Street analysts offering 12 month price targets forRepligen Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

11

Buy

1

Hold

0

Sell

Sentiment

By Acuity

60 / 339 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
help-icon Live chat